These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9449034)

  • 1. Role of IGF-I in muscular atrophy of aging.
    Borst SE; Lowenthal DT
    Endocrine; 1997 Aug; 7(1):61-3. PubMed ID: 9449034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone therapy in the elderly: implications for the aging brain.
    Hoffman AR; Lieberman SA; Ceda GP
    Psychoneuroendocrinology; 1992 Aug; 17(4):327-33. PubMed ID: 1438653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and strategies to counter muscle atrophy.
    Barton E; Morris C
    J Gerontol A Biol Sci Med Sci; 2003 Oct; 58(10):M923-6. PubMed ID: 14570860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
    Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1.
    Thum T; Hoeber S; Froese S; Klink I; Stichtenoth DO; Galuppo P; Jakob M; Tsikas D; Anker SD; Poole-Wilson PA; Borlak J; Ertl G; Bauersachs J
    Circ Res; 2007 Feb; 100(3):434-43. PubMed ID: 17234973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone, IGF-I, and the elderly. Clues to potential therapeutic interventions.
    Rosen CJ
    Endocrine; 1997 Aug; 7(1):39-40. PubMed ID: 9449029
    [No Abstract]   [Full Text] [Related]  

  • 7. Human growth hormone and human aging.
    Corpas E; Harman SM; Blackman MR
    Endocr Rev; 1993 Feb; 14(1):20-39. PubMed ID: 8491152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's Fountain revisited?
    Rosen CJ
    J Cell Biochem; 1994 Nov; 56(3):348-56. PubMed ID: 7876328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for sarcopenia and muscle weakness in older people.
    Borst SE
    Age Ageing; 2004 Nov; 33(6):548-55. PubMed ID: 15385272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan.
    Carter CS; Ramsey MM; Sonntag WE
    Trends Genet; 2002 Jun; 18(6):295-301. PubMed ID: 12044358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.
    Giovannini S; Marzetti E; Borst SE; Leeuwenburgh C
    Mech Ageing Dev; 2008 Oct; 129(10):593-601. PubMed ID: 18762207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults.
    Yuen KC; Dunger DB
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S55-61. PubMed ID: 16624605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the GH/IGF-1 axis contribute to skeletal sexual dimorphism? Evidence from mouse studies.
    Liu Z; Mohan S; Yakar S
    Growth Horm IGF Res; 2016 Apr; 27():7-17. PubMed ID: 26843472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human aging and the GH-IGF-I axis.
    Ghigo E; Arvat E; Gianotti L; Ramunni J; DiVito L; Maccagno B; Grottoli S; Camanni F
    J Pediatr Endocrinol Metab; 1996 Jun; 9 Suppl 3():271-8. PubMed ID: 8887170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone, insulin-like growth factor-1 and the aging brain.
    Ashpole NM; Sanders JE; Hodges EL; Yan H; Sonntag WE
    Exp Gerontol; 2015 Aug; 68():76-81. PubMed ID: 25300732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statement by the Growth Hormone Research Society on the GH/IGF-I axis in extending health span.
    Thorner MO
    J Gerontol A Biol Sci Med Sci; 2009 Oct; 64(10):1039-44. PubMed ID: 19587105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of the somatopause and its treatment.
    Hoffman AR; Lieberman SA; Butterfield G; Thompson J; Hintz RL; Ceda GP; Marcus R
    Endocrine; 1997 Aug; 7(1):73-6. PubMed ID: 9449036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth Hormone and Insulin-Like Growth Factor-1.
    Nicholls AR; Holt RI
    Front Horm Res; 2016; 47():101-14. PubMed ID: 27347885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of growth factors with particular focus on growth hormone and insulin-like growth factor-1 in the management of chronic kidney disease.
    Feldt-Rasmussen B; El Nahas M
    Semin Nephrol; 2009 Jan; 29(1):50-8. PubMed ID: 19121474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Growth hormone in adults. An elixir of youth?].
    Rainfray M; Hamon-Vilcot B; Cnockaert X; Pellerin J; Bouillanne O; Durand D; Piette F
    Therapie; 1995; 50(3):271-82. PubMed ID: 7667812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.